Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $401.76 million. The enterprise value is $273.24 million.

Market Cap	401.76M
Enterprise Value	273.24M

Important Dates

The next estimated earnings date is Thursday, March 20, 2025, before market open.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

CMPX has 137.59 million shares outstanding. The number of shares has increased by 8.22% in one year.

Current Share Class	137.59M
Shares Outstanding	137.59M
Shares Change (YoY)	+8.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.39%
Owned by Institutions (%)	42.46%
Float	82.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	472.66
Forward PS	n/a
PB Ratio	2.90
P/TBV Ratio	2.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	321.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 31.84, with a Debt / Equity ratio of 0.05.

Current Ratio	31.84
Quick Ratio	30.54
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.00% and return on invested capital (ROIC) is -22.55%.

Return on Equity (ROE)	-32.00%
Return on Assets (ROA)	-21.71%
Return on Invested Capital (ROIC)	-22.55%
Return on Capital Employed (ROCE)	-38.31%
Revenue Per Employee	$26,563
Profits Per Employee	-$1.49M
Employee Count	32
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.84% in the last 52 weeks. The beta is 0.98, so CMPX's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	+57.84%
50-Day Moving Average	2.38
200-Day Moving Average	1.66
Relative Strength Index (RSI)	48.30
Average Volume (20 Days)	1,370,029

Short Selling Information

The latest short interest is 2.75 million, so 2.00% of the outstanding shares have been sold short.

Short Interest	2.75M
Short Previous Month	3.19M
Short % of Shares Out	2.00%
Short % of Float	3.31%
Short Ratio (days to cover)	1.02

Income Statement

In the last 12 months, CMPX had revenue of $850,000 and -$47.76 million in losses. Loss per share was -$0.35.

Revenue	850,000
Gross Profit	850,000
Operating Income	-55.44M
Pretax Income	-47.24M
Net Income	-47.76M
EBITDA	-54.83M
EBIT	-55.44M
Loss Per Share	-$0.35

Full Income Statement

Balance Sheet

The company has $135.40 million in cash and $6.88 million in debt, giving a net cash position of $128.53 million or $0.93 per share.

Cash & Cash Equivalents	135.40M
Total Debt	6.88M
Net Cash	128.53M
Net Cash Per Share	$0.93
Equity (Book Value)	138.40M
Book Value Per Share	1.01
Working Capital	136.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$48.05 million and capital expenditures -$53,000, giving a free cash flow of -$48.10 million.

Operating Cash Flow	-48.05M
Capital Expenditures	-53,000
Free Cash Flow	-48.10M
FCF Per Share	-$0.35

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-6,522.82%
Pretax Margin	-5,618.47%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.22%
Shareholder Yield	-8.22%
Earnings Yield	-11.89%
FCF Yield	-11.97%

Analyst Forecast

The average price target for CMPX is $12.50, which is 328.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.50
Price Target Difference	328.08%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CMPX has an Altman Z-Score of 7.95 and a Piotroski F-Score of 1.

Altman Z-Score	7.95
Piotroski F-Score	1